The human malaria parasite Plasmodium falciparum increases red blood cell membrane permeability during infection to allow for import of nutrients and other solutes. Nguitragool et al. (2011) have now identified parasite-encoded CLAG3 proteins as key components of the import channel located on the erythrocyte membrane.
Nearly one million children succumb each year to fatal infections by the malaria parasite Plasmodium falciparum. Disease results from cycles of parasite growth and replication inside human red blood cells (RBCs) . These 48 hr cycles initiate with RBC invasion by P. falciparum merozoites that progress through morphologically distinct ring, trophozoite, and schizont stages. Intracellular development culminates with the production of 8 to 24 individual merozoites that emerge from the lysed RBC and invade new cells (eventually infecting up to 10%-20% of all RBCs in some individuals). To meet their metabolic requirements, trophozoites increase RBC membrane permeability, allowing soluble nutrients to enter. In this issue, Nguitragool et al. (2011) achieve a significant breakthrough as they identify P. falciparum proteins that directly contribute to solute uptake in infected RBCs. Ginsburg et al. (1983) first described pore-like properties, termed the ''New Permeability Pathway'' (NPP), in trophozoite-infected RBCs. The NPP is permeable to anions and small non-electrolytes including amino acids, vitamins, and the sugar alcohol sorbitol ( Figure 1A ). More recently, Desai et al. (2000) described the electrophysiological properties of a low conductance, inward-rectifying, anion-selective channel in parasitized RBCs, now called the ''plasmodial surface anion channel'' (PSAC). This channel has been touted as an attractive antimalarial target. Nonetheless, its molecular identity has remained elusive, and there has been a vigorous debate about whether PSAC/ NPP represents one or more distinct channels and whether PSAC is formed by parasite-encoded protein(s) or is instead an endogenous RBC channel activated following parasite infection (Bouyer et al., 2007; Staines et al., 2007) .
Desai and colleagues approached identification of PSAC components via a high-throughput screen to identify PSAC inhibitors. The increased permeability of trophozoite-infected RBCs renders parasites susceptible to sorbitolmediated osmotic lysis. Screening two P. falciparum strains, Dd2 and HB3, with a 50,000-compound chemical library yielded compounds that inhibited PSACassociated lysis, including some with differential activity. In electrophysiological studies using whole-cell and singlechannel patch-clamp recordings, one compound, ISPA-28, inhibited PSAC activity with 800-fold higher apparent affinity in the Dd2 strain compared to HB3.
HB3 and Dd2 were previously used in a genetic cross involving sexual recombination within mosquito vectors, followed by mammalian host infection. This cross yielded 35 recombinant progeny (Su et al., 1999) , which were used by Nguitragool et al. (2011) to screen for their degree of susceptibility to sorbitol lysis in the presence of ISPA-28. Most progeny partitioned into either HB3-or Dd2-type responses, although some intermediate phenotypes were observed.
Genetic mapping, using quantitative trait loci analysis, identified a chromosome 3 region containing 42 candidate genes. Fourteen genes from HB3 were individually integrated into Dd2 parasites and assayed for an effect on ISPA-28 inhibition. Reduced ISPA-28 affinity was observed upon transgene expression of two genes situated in tandem (clag3.1 and clag3.2, sharing 97% nucleotide identity). The genes belong to a family previously implicated in cytoadherence or parasite invasion. The association of clag genes with PSAC, although surprising, was confirmed by using allelic exchange experiments that revealed decreased sorbitol lysis in the presence of ISPA-28 in recombinant HB3 parasites expressing a chimeric form of HB3 and Dd2 clag3 genes.
Studies have shown that clag3.1 and clag3.2 are epigenetically regulated; at a single-cell level the expression of one appears to exclude the other (Comeaux et al., 2011 and references therein) . In an elegant series of experiments, Nguitragool et al. (2011) demonstrated that they could select for parasites expressing the Dd2 clag3.1 allele when they used ISPA-28 to block sorbitol-mediated lysis.
In reciprocal experiments, they used ISPA-43, a compound that appears to inhibit Dd2 CLAG3.2 protein, and were able to drive selection in the opposite direction. These experiments strongly support the model that the CLAG3 proteins are a component of, or regulate the action of, PSAC. CLAG proteins (also known as RhopH1) have previously been observed to form part of a high-molecular-weight RhopH complex (along with RhopH2 and 3) that assembles in the rhoptry organelles of mature merozoite-stage parasites. Upon merozoite contact with RBCs, rhoptry contents are secreted into the host cell. In the trophozoite stage, RhopH has been to shown to localize to the parasitophorous vacuole and RBC compartments (Vincensini et al., 2008) . Because PSAC components would be expected to localize to the RBC membrane, Nguitragool et al. (2011) tested whether pronase E could digest CLAG3 proteins in intact parasitized RBCs. CLAG3 was cleaved, suggesting that it was exposed on the cell surface. How CLAG3 proteins traffic to the RBC membrane, and how their involvement in PSAC function overlaps with their inclusion into RhopH complexes, remain to be elucidated.
This study provides convincing evidence that the CLAG3 proteins play a key role in determining PSAC activity. However, these proteins are not homologous to any of the five known anion channel gene families (Planells-Cases and Jentsch, 2009). Whether CLAG monomers assemble in a homomeric or heteromeric fashion to form a novel anion channel or whether CLAGs act as auxiliary subunits in a channel complex (involving yet-to-be-identified parasiteencoded proteins or endogenous RBC channels) remains to be determined ( Figure 1B ). Of note, precedents exist for auxiliary subunits modulating channel function, as exemplified by the mink/ KCNE1 auxiliary potassium channel subunits that affect channel selectivity and gating but do not directly line the channel (Pongs and Schwarz, 2010) . For CLAG3, the transmembrane topology is uncertain, with different algorithms (TMHMM versus PolyPhobius) predicting one to three transmembrane segments ( Figure 1C) . One potential transmembrane region (depicted in blue in Figure 1C ) contains 8 charged residues throughout the stretch of 60 residues. The C-terminal transmembrane segment predicted by all algorithms is flanked at both ends by negatively charged amino acids, an unlikely scenario for a domain lining an anion-selective channel. Nevertheless, HB3 parasites that were previously selected for resistance to leupeptin and that demonstrated altered PSAC properties were found, in the current study, to harbor a point mutation in the C-terminal segment in CLAG3.2. This finding suggests that this C-terminal transmembrane region contributes to PSAC function.
One direct means of assessing the role of CLAG3 in PSAC activity is now available with the recent report of a genetically modified P. falciparum line that expresses neither CLAG3.1 nor CLAG3.2 (Comeaux et al., 2011) . This line propagated at subtly reduced rates in vitro and displayed no invasion phenotype, arguing against a previously hypothesized role for these genes in parasite invasion. Electrophysiological and sorbitol lysis studies of these mutant parasites will be invaluable for determining whether the loss of CLAG3 proteins leads to partial or complete loss of PSAC activity or whether their function has been complemented in part by the homologs CLAG2 or CLAG8. That work will also be important to evaluate whether CLAG proteins remain viable antimalarial targets. More broadly, the identification of CLAG3 as a determinant of PSAC activity will now make it possible to pursue biochemical experiments assessing whether these proteins constitute part of the channel structure or whether they regulate the function of host-or parasite-derived channel proteins. To transport nutrients, parasites encode a number of transporters and channels (yellow) that actively or passively move solutes across the parasite plasma membrane and the parasitophorous vacuolar membrane. The RBC membrane permeability increases as the parasites mature, which has been attributed to a plasmodial surface anion channel (PSAC, purple). Nguitragool et al. (2011) identify the parasite-encoded CLAG3 proteins as a component of PSAC. (B) Although the CLAG3 proteins clearly modulate PSAC activity, there are several models for how they may do so. They may multimerize to form a channel (i); they may interact with other plasmodial or endogenous RBC proteins to form a channel (ii); or they may act as auxiliary proteins that activate plasmodial or endogenous channels (iii). (C) The clag3 genes encode a number of hydrophobic stretches (represented in blue and green), which were modeled as transmembrane regions (left). Only the C-terminal region is predicted with confidence to span more than 20 hydrophobic residues (right).
The transcription factor hypoxia-inducible factor 1 (HIF1) facilitates the induction of enzymes necessary for anaerobic glycolysis. Luo et al. (2011) now identify pyruvate kinase (PK)-M2 as an intriguing new interacting partner for HIF1, revealing a potential mechanism for the Warburg effect, an elevation in aerobic glycolytic metabolism frequently observed in cancer.
Cells exposed to low oxygen (hypoxia) undergo a number of phenotypic changes in order to survive, including a shift toward glycolysis, the oxygen-independent mechanism of producing ATP. A major factor driving increased glycolytic flux in hypoxic cells is induction of the transcription factor hypoxia-inducible factor 1 (HIF1), which consists of a stably expressed b subunit and an oxygen-labile a subunit (Wang et al., 1995) . Although the oxygen-dependent hydroxylation, ubiquitylation, and degradation of the a subunit provide the primary means of regulating HIF1 activity, other HIF1 modulators have been described in recent years, complicating the picture. In this issue, Luo et al. (2011) reveal a new aspect to this story, showing that the glycolytic isozyme pyruvate kinase-M2 can act as a coactivator for HIF1, greatly increasing the transcriptional activity of HIF1.
Pyruvate kinase (PK) is the final enzyme in glycolysis, converting phosphoenolpyruvate to pyruvate with the production of ATP. There are four forms of PK derived from two genes: PK-L and PK-R from PKLR and PK-M1 and PK-M2 from PKM2. Each isozyme is subject to different allosteric, substrate, and posttranslational regulation, making it one of the most highly regulated enzymes in the glycolytic pathway. The PK-M isoforms are produced by alternative splicing such that exon 9 is present in M1 and exon 10 in M2 (Mazurek, 2010) . Importantly, PK-M1 is in a permanent ''on'' state with rapid substrate turnover and ATP production, whereas PK-M2 can switch between low-and high-activity states, depending on the needs of the cell. They are therefore expressed in different cell types: M1 is present in a number of tissue types, including muscle and brain, and M2 in those with high anabolic requirements, such as proliferating cells (including all cells during embryogenesis). In tumors, the predominant form of PK expressed is the M2 variant (Christofk et al., 2008; Reinacher and Eigenbrodt, 1981) . This isozyme selection allows for the rapid proliferation observed in tumors but, paradoxically, may not always be consistent with the high lactate production also observed.
The hydroxylation of HIF1a is mediated by a family of prolyl hydroxylase domain (PHD) enzymes (Kaelin and Ratcliffe, 2008) . Of the three members (PHD1-3), PHD2 is thought to be the major hydroxylase that is responsible for HIF1a stability. Few targets have been described for the PHDs, which is in part due to the technical challenge of expressing fully active recombinant PHDs and definitively demonstrating changes in hydroxylation state of putative target proteins. The use of mass spectrometry (MS) is currently the gold standard for directly demonstrating the hydroxylation of proline residues in a peptide. It is often, however, not possible to specifically assign the mass change observed by MS to a specific proline residue due to the oxidation of other residues that are present in the peptide. Although this has hampered investigations into PHD substrates thus far, there is no doubt that there are more targets for these enzymes to be discovered.
In the current work, Luo et al. demonstrate that PHD3-mediated hydroxylation of PK-M2 increases the DNA binding of HIF1a and the coactivator p300 and that this leads to increased expression of HIF1 target genes (Figure 1 ). They describe a new hypoxia response element (HRE) in intron 1 of PKM2, showing that this gene is also a target of HIF1. As the
